Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Human mitochondrial transcription factor A functions in both nuclei and mitochondria and regulates cancer cell growth.

Han B, Izumi H, Yasuniwa Y, Akiyama M, Yamaguchi T, Fujimoto N, Matsumoto T, Wu B, Tanimoto A, Sasaguri Y, Kohno K.

Biochem Biophys Res Commun. 2011 Apr 29;408(1):45-51. doi: 10.1016/j.bbrc.2011.03.114. Epub 2011 Mar 29.

PMID:
21453679
2.

Involvement of riboflavin kinase expression in cellular sensitivity against cisplatin.

Hirano G, Izumi H, Yasuniwa Y, Shimajiri S, Ke-Yong W, Sasagiri Y, Kusaba H, Matsumoto K, Hasegawa T, Akimoto M, Akashi K, Kohno K.

Int J Oncol. 2011 Apr;38(4):893-902. doi: 10.3892/ijo.2011.938. Epub 2011 Feb 9.

PMID:
21308351
3.

Circadian disruption accelerates tumor growth and angio/stromagenesis through a Wnt signaling pathway.

Yasuniwa Y, Izumi H, Wang KY, Shimajiri S, Sasaguri Y, Kawai K, Kasai H, Shimada T, Miyake K, Kashiwagi E, Hirano G, Kidani A, Akiyama M, Han B, Wu Y, Ieiri I, Higuchi S, Kohno K.

PLoS One. 2010 Dec 23;5(12):e15330. doi: 10.1371/journal.pone.0015330.

4.

Forced Expression of ZNF143 Restrains Cancer Cell Growth.

Izumi H, Yasuniwa Y, Akiyama M, Yamaguchi T, Kuma A, Kitamura N, Kohno K.

Cancers (Basel). 2011 Oct 19;3(4):3909-20. doi: 10.3390/cancers3043909.

5.

Enhanced expression of nuclear factor I/B in oxaliplatin-resistant human cancer cell lines.

Kashiwagi E, Izumi H, Yasuniwa Y, Baba R, Doi Y, Kidani A, Arao T, Nishio K, Naito S, Kohno K.

Cancer Sci. 2011 Feb;102(2):382-6. doi: 10.1111/j.1349-7006.2010.01784.x. Epub 2010 Nov 19.

6.

Role of ZNF143 in tumor growth through transcriptional regulation of DNA replication and cell-cycle-associated genes.

Izumi H, Wakasugi T, Shimajiri S, Tanimoto A, Sasaguri Y, Kashiwagi E, Yasuniwa Y, Akiyama M, Han B, Wu Y, Uchiumi T, Arao T, Nishio K, Yamazaki R, Kohno K.

Cancer Sci. 2010 Dec;101(12):2538-45. doi: 10.1111/j.1349-7006.2010.01725.x. Epub 2010 Sep 23.

7.

Enhanced expression of PCAF endows apoptosis resistance in cisplatin-resistant cells.

Hirano G, Izumi H, Kidani A, Yasuniwa Y, Han B, Kusaba H, Akashi K, Kuwano M, Kohno K.

Mol Cancer Res. 2010 Jun;8(6):864-72. doi: 10.1158/1541-7786.MCR-09-0458. Epub 2010 Jun 8.

8.

Y-box binding protein-1 is a novel molecular target for tumor vessels.

Takahashi M, Shimajiri S, Izumi H, Hirano G, Kashiwagi E, Yasuniwa Y, Wu Y, Han B, Akiyama M, Nishizawa S, Sasaguri Y, Kohno K.

Cancer Sci. 2010 Jun;101(6):1367-73. doi: 10.1111/j.1349-7006.2010.01534.x. Epub 2010 Feb 16.

9.

Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth.

Shiota M, Izumi H, Tanimoto A, Takahashi M, Miyamoto N, Kashiwagi E, Kidani A, Hirano G, Masubuchi D, Fukunaka Y, Yasuniwa Y, Naito S, Nishizawa S, Sasaguri Y, Kohno K.

Cancer Res. 2009 Apr 1;69(7):3148-56. doi: 10.1158/0008-5472.CAN-08-2334. Epub 2009 Mar 24.

Supplemental Content

Loading ...
Support Center